Switching to coformulated rilpivirine (RPV), emtricitabine (FTC) and tenofovir alafenamide from either RPV, FTC and tenofovir disoproxil fumarate (TDF) or efavirenz, FTC and TDF: 96-week results from two randomized clinical trials-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Switching to coformulated rilpivirine (RPV), emtricitabine (FTC) and tenofovir alafenamide from either RPV, FTC and tenofovir disoproxil fumarate (TDF) or efavirenz, FTC and TDF: 96-week results from two randomized clinical trials

Published:2018-08-12 Issue:10 Volume:19 Page:724-733
ISSN:1464-2662
Container-title:HIV Medicine
language:en
Short-container-title:HIV Med

Author:

Hagins D¹,Orkin C²,Daar ES³,Mills A⁴,Brinson C⁵,DeJesus E⁶,Post FA⁷,Morales-Ramirez J⁸,Thompson M⁹,Osiyemi O¹⁰,Rashbaum B¹¹,Stellbrink H-J¹²,Martorell C¹³,Liu H¹⁴,Liu Y-P¹⁴,Porter D¹⁴,Collins SE¹⁴^ORCID,SenGupta D¹⁴,Das M¹⁴

Affiliation:

1. Georgia Department of Public Health; Chatham Care Center; Savannah GA USA

2. Grahame Hayton Unit; Royal London Hospital and Queen Mary University; London UK

3. Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center; Torrance CA USA

4. Mills Clinical Research; Los Angeles CA USA

5. Central Texas Clinical Research; Austin TX USA

6. Orlando Immunology Center; Orlando FL USA

7. King's College Hospital; London UK

8. Clinical Research Puerto Rico Inc.; San Juan Puerto Rico

9. AIDS Research Consortium of Atlanta; Atlanta GA USA

10. Triple O Research Institute PA; West Palm Beach FL USA

11. Capital Medical Associates; Washington DC USA

12. ICH Study Center; Hamburg Germany

13. The Research Institute; Springfield MA USA

14. Gilead Sciences Inc; Foster City CA USA

Publisher

Wiley

Subject

Pharmacology (medical),Infectious Diseases,Health Policy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/hiv.12664/fullpdf

Reference25 articles.

1. Association between efavirenz as initial therapy for HIV-1 infection and increased risk for suicidal ideation or attempted or completed suicide: an analysis of trial data;Mollan;Ann Intern Med,2014

2. Efavirenz: a decade of clinical experience in the treatment of HIV;Maggiolo;J Antimicrob Chemother,2009

3. Adverse events associated with nevirapine and efavirenz-based first-line antiretroviral therapy: a systematic review and meta-analysis;Shubber;AIDS,2013

4. Brief report: randomized, double-blind comparison of tenofovir alafenamide (TAF) vs tenofovir disoproxil fumarate (TDF), each coformulated with elvitegravir, cobicistat, and emtricitabine (E/C/F) for initial HIV-1 treatment: week 144 results;Arribas;J Acquir Immune Defic Syndr,2017

5. Brief report: long-term (96-Week) efficacy and safety after switching from tenofovir disoproxil fumarate to tenofovir alafenamide in HIV-infected, virologically suppressed adults;Raffi;J Acquir Immune Defic Syndr,2017

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety of tenofovir alafenamide in people with HIV who experienced proximal renal tubulopathy on tenofovir disoproxil;AIDS;2024-06-27

2. Clinical considerations when switching antiretroviral therapy;Expert Review of Clinical Pharmacology;2024-06-17

3. Cardiometabolic health in people with HIV: expert consensus review;Journal of Antimicrobial Chemotherapy;2024-04-24

4. Tenofovir amibufenamide vs tenofovir alafenamide for treating chronic hepatitis B: A real-world study;World Journal of Gastroenterology;2023-11-28

5. Lipid profile after switching from TDF (tenofovir disoproxil)-containing to TAF (tenofovir alafenamide)-containing regimen in virologically suppressed people living with HIV;Journal of Medical Science;2023-09-26

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3